| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |